A year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in ...

The yearlong family feud surrounding Hanmi Pharmaceutical Group is drawing to an end as Hanmi Science Director Lim Jong-yoon moves to reconcile with his mother, Hanmi Pharm’s Chairman Song Yeong ...

Flu surge boosts demand for medications and diagnostics in South Korea Flu season drives sharp rise in pharmaceutical sales ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The management rights dispute of Hanmi Pharmaceutical Group, which has been ongoing for nearly a year between the founder's family, including daughters and brothers, has reached a new phase.

SEOUL, South Korea, Nov. 24, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...

Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market, this time to Shanghai-based Hansoh Pharmaceutical Group Co. Ltd. for its investigational preclinical oral ...

SEOUL, South Korea, Nov. 24, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...